{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:07Z","timestamp":1787020147969,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2931-6","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T20:12:39Z","timestamp":1514491959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Improved performance of Xpert MTB\/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong\u2019oto infectious diseases hospital in\u00a0Tanzania"],"prefix":"10.1186","volume":"17","author":[{"given":"Peter M.","family":"Mbelele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stellah G.","family":"Mpagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mecky I.","family":"Matee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"2931_CR1","unstructured":"National Tuberculosis and Leprosy Programme (NTLP). United Republic of Tanzania Ministry of Health and Social Welfare. Manual for the Management of Tuberculosis and Leprosy, Sixth Edition. 2013."},{"key":"2931_CR2","unstructured":"World Health Organisation (WHO). Global tuberculosis report 2016. World Health Organisation. 20 Avenue Appia, 1211 Geneva 27, Switzerland; 2016."},{"issue":"2","key":"2931_CR3","first-page":"33","volume":"8","author":"M Raviglione","year":"2015","unstructured":"Raviglione M, Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infect Dis Rep. 2015;8(2):33\u20137.","journal-title":"Infect Dis Rep"},{"issue":"10","key":"2931_CR4","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1365-3156.2007.01907.x","volume":"12","author":"GS Kibiki","year":"2007","unstructured":"Kibiki GS, Mulder B, Van Der Ven AJAM, Sam N, Boeree MJ, Van Der Zanden A, Dolmans WMV. Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. Tuberculosis in bronchoalveolar lavage fluid. Trop Med Int Heal. 2007;12(10):1210\u20137.","journal-title":"Trop Med Int Heal"},{"key":"2931_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/128057","volume":"2012","author":"SG Mpagama","year":"2012","unstructured":"Mpagama SG, Mtabho C, Mwaigwisya S, Mleoh LJ, Boer IMS, Heysell SK, Houpt ER, Kibiki GS. Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania. Tuberc Res Treat. 2012;2012:1\u20135.","journal-title":"Tuberc Res Treat"},{"issue":"10","key":"2931_CR6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1473-3099(06)70602-8","volume":"6","author":"KR Steingart","year":"2006","unstructured":"Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, Cunningham J, Urbanczik R, Perkins MD, Aziz MA, Pai M. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(10):664\u201374.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2931_CR7","first-page":"8","volume":"47","author":"World Health Organisation (WHO)","year":"2009","unstructured":"World Health Organisation (WHO). Same-day diagnosis of tuberculosis by microscopy: policy statement. World Heal Organ Doc. 2009;47(1):8\u201314.","journal-title":"World Heal Organ Doc"},{"key":"2931_CR8","unstructured":"World Health Organisation (WHO). Rapid implementation of the Xpert MTB\/RIF diagnostic test. Technical and operational \u201cHow to\u201d practical considerations. World Health Organisation Doc. 2011;WHO\/HTM\/TB:1\u201334."},{"key":"2931_CR9","first-page":"1","volume":"1","author":"K Steingart","year":"2014","unstructured":"Steingart K, Schiller I, Dj H, Pai M, Cc B, Dendukuri N, Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert \u00ae MTB \/ RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Libr. 2014;1:1\u2013132.","journal-title":"Cochrane Libr"},{"issue":"9776","key":"2931_CR10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","volume":"377","author":"CC Boehme","year":"2011","unstructured":"Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011 Apr 30;377(9776):1495\u2013505.","journal-title":"Lancet"},{"issue":"9915","key":"2931_CR11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","volume":"383","author":"G Theron","year":"2014","unstructured":"Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M, Dowdy D, Pym A, Mwaba P, Mason P, Peter J, Dheda K. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2014 Feb 1;383(9915):424\u201335.","journal-title":"Lancet"},{"issue":"1","key":"2931_CR12","first-page":"1","volume":"19","author":"EW Mollel","year":"2017","unstructured":"Mollel EW, Chilongola JO, Mpagama SG, Kibiki GS. Evaluation of XpertMTB\/Rif performance for diagnosis of tuberculosis among HIV positive patients in northern Tanzania. Tanzan J Health Res. 2017;19(1):1\u20139.","journal-title":"Tanzan J Health Res"},{"key":"2931_CR13","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Laboratory detection and identification of mycobacteria; approved standard. CLSI document M48-A. 2008."},{"issue":"44","key":"2931_CR14","first-page":"5107","volume":"7","author":"M Darwish","year":"2013","unstructured":"Darwish M, Abd M, Wadood E, Alnagdi H. Diagnostic assessment of Xpert MTB \/ RIF in a sample of mycobacterium tuberculosis Egyptian patients. African J. Microbiol Res. 2013;7(44):5107\u201313.","journal-title":"Microbiol Res"},{"key":"2931_CR15","unstructured":"Cepheid\u00ae. Xpert MTB \/ RIF Package Insert. 2009. \nhttp:\/\/tbevidence.org\/documents\/rescentre\/sop\/XpertMTB_Broch_R9_EU.pdf"},{"issue":"4","key":"2931_CR16","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.03619-14","volume":"53","author":"NJ Dharan","year":"2015","unstructured":"Dharan NJ, Amisano D, Mboowa G, Ssengooba W, Blakemore R, Kubiak RW, Armstrong DT, Jones M, Manabe YC, Joloba ML, Ellner JJ, Dorman SE, Alland D. Improving the sensitivity of the Xpert MTB\/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation. J Clin Microbiol. 2015;53(4):1258\u201363.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2931_CR17","first-page":"1","volume":"14","author":"AJ Meremo","year":"2012","unstructured":"Meremo AJ, Kidenya BR, Mshana SE, Kabangila R, Kataraihya JB. High prevalence of tuberculosis among adults with fever admitted at a tertiary hospital in north-western Tanzania. Tanzan J Health Res. 2012;14(3):1\u20139.","journal-title":"Tanzan J Health Res."},{"key":"2931_CR18","unstructured":"Tripathi K, Tripathi PC, Nema S, Shrivastava AK, Dwiwedi K. Modified Petroff \u2019 s Method : an Excellent Simplified Decontamination Technique in Comparison with Petroff \u2019 s Method 2014;10(3):461\u20134."},{"key":"2931_CR19","first-page":"1","volume":"302","author":"W Ssengooba","year":"2016","unstructured":"Ssengooba W, Respeito D, Mambuque E, Blanco S, Bulo H, Mandomando I, De JBC, Cobelens FG. Do Xpert MTB \/ RIF cycle threshold values provide information about patient delays for tuberculosis diagnosis ? PLoS One. 2016;302:1\u201310.","journal-title":"PLoS One"},{"key":"2931_CR20","unstructured":"MedCalc Statistical Software version 16.4.3 (MedCals software bvba, Ostend, Belgium; 2016. \nhttps:\/\/www.medcalc.org\n\n."},{"issue":"1","key":"2931_CR21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1471-2334-13-352","volume":"13","author":"M Shah","year":"2013","unstructured":"Shah M, Chihota V, Coetzee GJ, Churchyard GJ, Dorman SE. Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa. BMC Infect Dis. 2013;13(1):352.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"2931_CR22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s40273-015-0279-6","volume":"33","author":"YV Laurence","year":"2015","unstructured":"Laurence YV, Griffiths UK, Vassall A, Laurence YV. Costs to health services and the patient of treating tuberculosis : a systematic literature review. PharmacoEconomics. 2015;33(9):939\u201355.","journal-title":"PharmacoEconomics"},{"issue":"6","key":"2931_CR23","first-page":"580","volume":"64","author":"K Chang","year":"2012","unstructured":"Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, Deng S, Chen M. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB\/RIF assay: a meta-analysis. J Inf Secur. 2012 Jun;64(6):580\u20138.","journal-title":"J Inf Secur"},{"issue":"8","key":"2931_CR24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/civ1223","volume":"62","author":"G Theron","year":"2016","unstructured":"Theron G, Venter R, Calligaro G, Smith L, Limberis J, Meldau R, Chanda D, Esmail A, Peter J, Dheda K. Xpert MTB\/RIF Results in Patients With previous tuberculosis: can we distinguish true from false positive results? Clin Infect Dis 2016;62(8):995\u20131001.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2931_CR25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12866-015-0566-6","volume":"15","author":"DA Geleta","year":"2015","unstructured":"Geleta DA, Megerssa YC, Gudeta AN, Akalu GT, Debele MT, Tulu KD, Xpert MTB. RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015;15(1):220.","journal-title":"BMC Microbiol"},{"key":"2931_CR26","unstructured":"Mpagama Stellah, Chongolo Anna, Lyimo Jonson, Kisonga Riziki, Heysell Scott ME. Gridlock from Diagnosis to Treatment of Multidrug Resistant Tuberculosis (MDR-TB) in Tanzania: Patient Perspectives from Focus Group Discussions. In: 48th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union). Guadalajara Mexico; 2017."},{"issue":"1","key":"2931_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/JCM.01463-09","volume":"48","author":"D Helb","year":"2010","unstructured":"Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Ngoc Lan NT, Jones-L\u00f3pez EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D. Rapid detection of mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229\u201337.","journal-title":"J Clin Microbiol"},{"key":"2931_CR28","unstructured":"National Tuberculosis and Leprosy Programme (NTLP). United Republic of Tanzania. Ministry of Health and social welfare. Operational Guidelines for the Management of Drug Resistant TB in Tanzania, First Edition. 2012."},{"key":"2931_CR29","unstructured":"World Health Organisation (WHO). Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. 2014."},{"issue":"4","key":"2931_CR30","first-page":"1","volume":"10","author":"TJ Nagu","year":"2015","unstructured":"Nagu TJ, Aboud S, Mwiru R, Matee M, Fawzi W, Mugusi F. Multi drug and other forms of drug resistant tuberculosis are uncommon among treatment na\u00efve tuberculosis patients in Tanzania. PLoS One. 2015;10(4):1\u201310.","journal-title":"PLoS One"},{"issue":"3","key":"2931_CR31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/cid\/cir824","volume":"54","author":"G Theron","year":"2012","unstructured":"Theron G, Pinto L, Peter J, Mishra HK, Mishra HK, Van Zyl-smit R, Sharma SK, Dheda K. The use of an automated quantitative polymerase chain reaction (Xpert MTB\/RIF) to predict the sputum smear status of tuberculosis patients. Clin Infect Dis. 2012;54(3):384\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2931-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T20:13:05Z","timestamp":1514491985000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2931-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2931-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"808"}}